---
title: "Onconetix says Realbotix acquisition expected to close in H2 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291937819.md"
description: "Onconetix agreed to acquire Realbotix LLC in an all-stock transaction. The closing is expected in the second half of 2026, pending shareholder approval and regulatory clearances. Realbotix develops AI-powered humanoid robots for enterprise and consumer applications."
datetime: "2026-07-07T13:02:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291937819.md)
  - [en](https://longbridge.com/en/news/291937819.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291937819.md)
generator: "portal-rs"
---

# Onconetix says Realbotix acquisition expected to close in H2 2026

-   Onconetix agreed on Feb. 12, 2026 to acquire Realbotix LLC in an all-stock share exchange for 100% of the unit. \* Closing is expected in the second half of 2026, subject to shareholder vote, regulatory clearances, and other closing conditions. \* Realbotix is a unit of Realbotix Corp. and develops AI-powered humanoid robots for enterprise and consumer uses. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Onconetix Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607070900PRIMZONEFULLFEED9757928) on July 07, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [ONCO.US](https://longbridge.com/en/quote/ONCO.US.md)

## Related News & Research

- [Onco-Innovations reports interim three-species microsome metabolism results for ONC010 API A83B4C63](https://longbridge.com/en/news/298509082.md)
- [From Molecule to Medicine: Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) Aligns ONC010 for Clinical Development](https://longbridge.com/en/news/298347552.md)
- [Inter Parfums announces availability of 2026 half-year report](https://longbridge.com/en/news/298413126.md)
- [Essex Property Trust declares Q3 2026 dividend of R$ 0.89 per unit](https://longbridge.com/en/news/298322539.md)
- [Annaly Capital declares Q3 2026 dividend of $0.75 per share](https://longbridge.com/en/news/298499808.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**